Coagulation Factors in Controlling Traumatic Bleeds: FFP, PCC, or ...
Coagulation Factors in Controlling Traumatic Bleeds: FFP, PCC, or ...
Coagulation Factors in Controlling Traumatic Bleeds: FFP, PCC, or ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REFERENCES (cont<strong>in</strong>ued)<br />
28. Downes K, Wilson E, Yomtovian R, et al. Serial measurements of clott<strong>in</strong>g fact<strong>or</strong>s <strong>in</strong> thawed plasma st<strong>or</strong>ed f<strong>or</strong> 5<br />
days. Transfusion 2001; 41(4):570.<br />
29. Samama CM. Prothromb<strong>in</strong> complex concentrates: a brief review. Eur J Anaesthesiol 2008; 25(10):784-9.<br />
30. Grottke O, Braunschweig T, Spronk HM, et al. Increas<strong>in</strong>g concentrations of prothromb<strong>in</strong> complex concentrate<br />
<strong>in</strong>duce dissem<strong>in</strong>ated <strong>in</strong>travascular coagulation <strong>in</strong> a pig model of coagulopathy with blunt liver <strong>in</strong>jury.<br />
Blood 2011; 118(7):1943-51.<br />
31. Dager WE. Us<strong>in</strong>g prothromb<strong>in</strong> complex concentrates to rapidly reverse <strong>or</strong>al anticoagulant effects. Ann<br />
Pharmacother 2011; 45(7):1016-20.<br />
32. Godier A, Susen S, Samama CM. Treatment of massive bleed<strong>in</strong>g with prothromb<strong>in</strong> complex concentrate:<br />
argument aga<strong>in</strong>st. J Thromb Haemost 2010; 8(12):2592-5.<br />
33. Sørensen B, Spahn DR, Innerhofer P, et al. Cl<strong>in</strong>ical review: prothromb<strong>in</strong> complex concentrates – evaluation of<br />
safety and thrombogenicity. Crit Care 2011; 15(1):201 (ePub).<br />
34. Dickneite G, Pragst I. Prothromb<strong>in</strong> complex concentrate vs fresh frozen plasma f<strong>or</strong> reversal of dilutional<br />
coagulopathy <strong>in</strong> a p<strong>or</strong>c<strong>in</strong>e trauma model. Brit J Anaesth 2009; 102(3):345-54.<br />
35. NovoSeven ® RT [package <strong>in</strong>sert]. Novo N<strong>or</strong>disk A/S, Bagsvaerd, Denmark; Revised January 2010. Accessed<br />
February 23, 2012.<br />
36. Rizoli SB, Boffard KD, Riou B, et al. Recomb<strong>in</strong>ant activated fact<strong>or</strong> VII as an adjunctive therapy f<strong>or</strong> bleed<strong>in</strong>g<br />
control <strong>in</strong> severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit<br />
Care 2006; 10(6):R178.<br />
37. DeLoughery TG. Management of bleed<strong>in</strong>g emergencies: when to use recomb<strong>in</strong>ant activated Fact<strong>or</strong> VII. Expert<br />
Op<strong>in</strong> Pharmaco 2006; 7(1):25-34.<br />
38. Kenet G, Walden R, Eldad A, et al. Treatment of traumatic bleed<strong>in</strong>g with recomb<strong>in</strong>ant fact<strong>or</strong> VIIa. Lancet 1999;<br />
354(9193):1879.<br />
39. Nishijima DK, Dager WE, Schrot RJ, et al. The efficacy of fact<strong>or</strong> VIIa <strong>in</strong> emergency department patients with<br />
warfar<strong>in</strong> use and traumatic <strong>in</strong>tracranial hem<strong>or</strong>rhage. Acad Emerg Med 2010; 17(3):244-51.<br />
40. Sarode R, Matevosyan K, Bhagat R, et al. Rapid warfar<strong>in</strong> reversal: a 3-fact<strong>or</strong> prothromb<strong>in</strong> complex concentrate<br />
and recomb<strong>in</strong>ant fact<strong>or</strong> VIIa cocktail f<strong>or</strong> <strong>in</strong>tracerebral hem<strong>or</strong>rhage. J Neurosurg published onl<strong>in</strong>e ahead of<br />
pr<strong>in</strong>t 2011.<br />
41. Kal<strong>in</strong>a M, T<strong>in</strong>koff G, Gbadebo A, et al. A protocol f<strong>or</strong> the rapid n<strong>or</strong>malization of INR <strong>in</strong> trauma patients with<br />
<strong>in</strong>tracranial hem<strong>or</strong>rhage on prescribed warfar<strong>in</strong> therapy. Am Surgeon 2008; 74(9):858-61.<br />
42. Barletta JF, Ahrens CL, Tyburski JG, et al. A review of recomb<strong>in</strong>ant fact<strong>or</strong> VII f<strong>or</strong> refract<strong>or</strong>y bleed<strong>in</strong>g <strong>in</strong><br />
nonhemophilic trauma patients. J Trauma 2005; 58(3):646-51.<br />
43. Pape HC, Erhardtsen E, Meyer C, et al. Recomb<strong>in</strong>ant fact<strong>or</strong> VIIa f<strong>or</strong> life-threaten<strong>in</strong>g hem<strong>or</strong>rhage <strong>in</strong> trauma<br />
patients: review of the literature. Eur J Trauma 2006; 32(5):439-48.<br />
44. Boffard KD, Riou B, Warren B, et al. Recomb<strong>in</strong>ant fact<strong>or</strong> VIIa as adjunctive therapy f<strong>or</strong> bleed<strong>in</strong>g control <strong>in</strong><br />
severely <strong>in</strong>ured trauma patients: two parallel randomized, placebo-controlled, double-bl<strong>in</strong>d cl<strong>in</strong>ical trials.<br />
J Trauma 2005; 59:8-18.<br />
45. Levi M, Levy JH, Anderson HF. Safety of recomb<strong>in</strong>ant activated fact<strong>or</strong> VII <strong>in</strong> randomized cl<strong>in</strong>ical trials. N Eng J<br />
Med 2010; 363(19):1791-800.<br />
46. Ferrari L, Podda GM. Off-label use of recomb<strong>in</strong>ant activated coagulation fact<strong>or</strong> VII f<strong>or</strong> bleed<strong>in</strong>g may raise the<br />
risk of arterial thrombosis. Intern Emerg Med 2011; 6(3):261-2.<br />
47. Poon BB, Witmer C, Pruemer J. <strong>Coagulation</strong> Dis<strong>or</strong>ders. In: DiPiro JT, Talbert RL, Yee GC, et al, eds.<br />
Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New Y<strong>or</strong>k, NY: McGraw-Hill; 2011.<br />
http://www.accesspharmacy.com/content.aspx?aID=8000061. Accessed February 26, 2012.<br />
48. Injury Severity Sc<strong>or</strong><strong>in</strong>g. Surgical Critical Care.<br />
http://www.surgicalcriticalcare.net/Resources/<strong>in</strong>jury_severity_sc<strong>or</strong><strong>in</strong>g.pdf. May 29, 2001. Accessed<br />
February 4, 2012.<br />
49. Profiln<strong>in</strong>e ® SD [package <strong>in</strong>sert]. Grifols Biologicals Inc., Los Angeles, CA: 2004. Accessed February 23, 2012.<br />
50. Bebul<strong>in</strong> ® VH [package <strong>in</strong>sert]. Baxter Healthcare C<strong>or</strong>p<strong>or</strong>ation: Westlake Village, CA: Revised September 2006.<br />
Accessed February 23, 2012.<br />
51. Doherty DE. Glasgow Coma Scale. Medscape Pharmacists. http://www.medscape.com/viewarticle/412341.<br />
March 20, 2011. Accessed February 9, 2012.<br />
52. Maas AI, Hukkelhoven CW, Marshall LF, et al. Prediction of outcome <strong>in</strong> traumatic bra<strong>in</strong> <strong>in</strong>jury with computed<br />
tomographic characteristics: a comparison between the computed tomographic classification and<br />
comb<strong>in</strong>ations of computed tomographic predict<strong>or</strong>s. Neurosurgery 2005; 57(6):1173-82.<br />
R. Sohraby 17